PEMETREXED
- Product NDC
- 0338-0722
- 11-digit product format
- 003380722
- Labeler code
- 0338
- Product ID
- 0338-0722_94c2f5f8-332c-4552-9919-0ae23b014788
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PEMETREXED
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENTRICULAR
- Labeler
- Baxter Healthcare Corporation
- Application
- ANDA214436
- Marketing category
- ANDA
- Marketing start
- 2022-08-18
- Marketing end
- 0000-00-00
- Substance
- PEMETREXED DISODIUM HEPTAHYDRATE
- Active strength
- 500 mg/50mL
- Pharmacologic classes
- Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0338-0722 | PEMETREXED INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [BAXTER HEALTHCARE COMPANY] | 6 | Legacy NDC | 20250519_9a93c625-ae03-4aa7-8603-45a335210080.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0338-0722-01 | 00338072201 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0338-0722-01) > 50 mL in 1 VIAL, SINGLE-DOSE | 2022-08-18 | 0000-00-00 | No | No | Current |